# |
Organization |
Presenter |
Title |
1 | IMA |
Guia Bertuzzi | The potential of Croma continuous coater |
2 | Glatt |
Ed Godek |
Direct Tableting a mixture of a powder matrix and API loaded pellets (MUPS) |
3 | MIT |
Alexis B. Dubs |
Continuous Manufacturing Testbed Development and Data Release for a Monoclonal Antibody Production Process |
4 | Procegence |
Nima Yazdanpanah |
Model-based Product and Process Development for Accelerated and Efficient Scale-up and Tech-transfer |
5 | Lilly |
Wyatt J Roth |
Advancements in the Application of Continuous Manufacturing at Eli Lilly and Company |
6 | Sanofi |
Yuanli Song |
Manufacturability Assessment for Adeno-Associated Virus (AAV) CMC Development. |
7 | Sanofi |
Kevin Brower |
End-to-End Integrated Continuous Biomanufacturing at Sanofi: Case Studies in Advancing Advanced Manufacturing |
8 | ArrantaBio |
Jing Zhu |
A Complete, End-to-End CDMO Solution for Plasmid, RNA, LNP Formulation and Injectable Sterile Drug Product |
9 | Continuus |
Bhakti Halkude |
Continuous Manufacturing of OSDs with Extrusion Injection Molding- a single unit operation continuous tablet manufacturing technology |
10 | Continuus |
Wei Wu |
Implementation of the integrated continuous manufacturing (ICM) technology for drug substance production |
11 | Rutgers University |
Carlos Ortega-Zuniga |
A Real-Time Quality Control Toolbox for Predicting the Dissolution Profile of Tablets from a Continuous Pharmaceutical Manufacturing Pilot-Plant Using a Non-Destructive NIR Spectroscopy Method |
12 | Rutgers University | Zankrut Vyas |
Enhancing the Oral Bioavailability of Poorly Soluble Drug through Twin-Screw Melt Coating and Granulation |
13 | MIT/Takeda |
Thomas Toupy |
Integrated end-to-end continuous flow manufacturing platform towards advanced API intermediate. |
14 | MIT | Francesco Destro |
Mechanistic Modeling to Enhance Continuous Manufacturing of Recombinant Adeno-Associated Virus with Insect Cells |
15 | CMAC |
Massimo Bresciani |
CMAC Pillar 4: Exemplary Translation to Industry. Driving the impact of research |
16 | CMAC |
Cameron Brown |
Towards a Crystallisation Classification System for Pharmaceutical Ingredients |
17 | CMAC |
Kenny Smith |
Continuous Crystallisation & Advanced Characterisation – Case Studies |
18 | CMAC |
Catriona Clark |
Digital Design and Manufacture of Amorphous Materials |
19 | CMAC |
Chantal Mustoe |
Quality by Digital Design (QbDD): An Integrated Approach to Digital Transformation of CMC and Product Quality |
20 | CMAC |
Jonathan Moores |
Digital Medicines Manufacturing (DM2) Centre |
21 | Sanofi |
Ying Liu |
Development and Scale-up of Adeno-Associated Virus (AAV) Transient Transfection Manufacturing Process with Improved Productivity |
22 | Parc/Xerox |
Nazly Pirmoradi |
Hot-melt Inkjet 3D printing of Lipid-based Solid Oral Dosage Forms |
23 | FDA |
Adil Mohammad |
Development of Continuous Synthesis and Crystallization Reactor System for Carbamazepine using Integrated Process Analytical Technologies |
24 | FDA |
Thomas O’Connor |
Applications of Residence Time Distribution Modeling in Continuous Pharmaceutical Manufacturing |